Areteia Therapeutics to wind down after terminating Phase 3 asthma studies
Areteia Therapeutics在终止三期哮喘研究后将关闭公司

Areteia Therapeutics, one of the biotech industry’s biggest recent startup bets in respiratory illness, has decided to wind down, according to a source familiar with the decision.
据一位知情人士透露，Areteia Therapeutics，这家生物科技行业近年来在呼吸系统疾病领域备受押注的初创公司之一，已决定关闭业务。